Peginterferon Alfa-2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy*

Mark Sulkowski, Teresa L. Wright, Stephen J. Rossi, Sanjeev Arora, Matthew W. Lamb, Ka Wang, J. Gries, Sreeni YalamanchiliClinical 2005 · DOI

Abstract

Peginterferon alfa-2a does not appreciably alter the pharmacokinetics of methadone.
BibTeX
@inproceedings{sulkowski2005peginterferon,
  author = {Mark Sulkowski and Teresa L. Wright and Stephen J. Rossi and Sanjeev Arora and Matthew W. Lamb and Ka Wang and J. Gries and Sreeni Yalamanchili},
  title = {{Peginterferon Alfa-2a Does Not Alter the Pharmacokinetics of Methadone in Patients with Chronic Hepatitis C Undergoing Methadone Maintenance Therapy*}},
  booktitle = {Clinical},
  year = {2005},
  doi = {10.1016/j.clpt.2004.09.008},
}

Loading related content...

Figure